Associated Papers
-318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients.
Oliveira VB et al.
International Journal of Immunogenetics, 2017
Association of CTLA-4 gene polymorphisms -318C/T and +49A/G and Hashimoto's thyroidits in Zahedan, Iran.
Narooie-Nejad M et al.
Biomedical Reports, 2017
The influence of CTLA-4 single nucleotide polymorphisms on acute kidney allograft rejection in Turkish patients.
Ruhi Ç et al.
Clinical Transplantation, 2015
Association of CTLA-4 variants with susceptibility to inflammatory bowel disease: a meta-analysis.
Zhang M et al.
Human Immunology, 2014
CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.
Duan S et al.
Molecular Biology Reports, 2011
Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians.
Benmansour J et al.
Clinical and Vaccine Immunology : Cvi, 2010
CTLA4 gene variations and haplotypes in patients with lung cancer.
Khaghanzadeh N et al.
Cancer Genetics and Cytogenetics, 2010
CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia.
Jones AL et al.
Brain, Behavior, and Immunity, 2009
Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis.
Balbi G et al.
Clinical and Experimental Immunology, 2007
Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer.
Erfani N et al.
Cancer Genetics and Cytogenetics, 2006
Select a paper to view details